Int J Biol Sci 2023; 19(7):2002-2005. doi:10.7150/ijbs.83574 This issue Cite

Editorial

Vistas in Non-Small Cell Lung Cancer (NSCLC) Treatment: of Kinome and Signaling Networks

Dimitrios J. Stravopodis1✉, Kostas A. Papavassiliou2, Athanasios G. Papavassiliou3

1. Section of Cell Biology and Biophysics, Department of Biology, National and Kapodistrian University of Athens, 15701 Athens, Greece.
2. First University Department of Respiratory Medicine, 'Sotiria' Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
3. Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, Athens 11527, Greece.

Citation:
Stravopodis DJ, Papavassiliou KA, Papavassiliou AG. Vistas in Non-Small Cell Lung Cancer (NSCLC) Treatment: of Kinome and Signaling Networks. Int J Biol Sci 2023; 19(7):2002-2005. doi:10.7150/ijbs.83574. https://www.ijbs.com/v19p2002.htm
Other styles

File import instruction

Abstract

Graphic abstract

Non-small cell lung cancer (NSCLC) is the prevailing lung cancer type, accounting for ~85% of all lung cancer cases. Despite their initial promise, current chemotherapeutic protocols are reaching their limits. This necessitates the prompt discovery of new molecular drivers and the development of novel regimens for advanced NSCLC. Herein, we pose that there is a need to systematically profile the human kinome activity of NSCLC. Using available state-of-the-art technologies, a wide gamut of kinase activities can be simultaneously mapped and quantified specifically in the primary or metastatic cancer states, with oncogenic kinase functions being likely linked to mutation signatures and malignant features of NSCLC. New chemical compound libraries can then be screened for kinase inhibitory properties in preclinical model systems, with presumptive induction of programmed cell-death subroutines and signaling-disintegration routes serving as major outputs of novel inhibitor tumor-suppressor potentials.

Keywords: Non-small cell lung cancer (NSCLC), Human kinome activity, Serine/threonine protein kinases, Tyrosine protein kinases, Signal transduction networks, Therapeutic strategies


Citation styles

APA
Stravopodis, D.J., Papavassiliou, K.A., Papavassiliou, A.G. (2023). Vistas in Non-Small Cell Lung Cancer (NSCLC) Treatment: of Kinome and Signaling Networks. International Journal of Biological Sciences, 19(7), 2002-2005. https://doi.org/10.7150/ijbs.83574.

ACS
Stravopodis, D.J.; Papavassiliou, K.A.; Papavassiliou, A.G. Vistas in Non-Small Cell Lung Cancer (NSCLC) Treatment: of Kinome and Signaling Networks. Int. J. Biol. Sci. 2023, 19 (7), 2002-2005. DOI: 10.7150/ijbs.83574.

NLM
Stravopodis DJ, Papavassiliou KA, Papavassiliou AG. Vistas in Non-Small Cell Lung Cancer (NSCLC) Treatment: of Kinome and Signaling Networks. Int J Biol Sci 2023; 19(7):2002-2005. doi:10.7150/ijbs.83574. https://www.ijbs.com/v19p2002.htm

CSE
Stravopodis DJ, Papavassiliou KA, Papavassiliou AG. 2023. Vistas in Non-Small Cell Lung Cancer (NSCLC) Treatment: of Kinome and Signaling Networks. Int J Biol Sci. 19(7):2002-2005.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image